Trial intelligence / Profile preview

PRGF in Knee Osteoarthritis

NCT00728611Phase 3Completed

Sponsor
Meir Medical Center
Start
Jan 2008
Primary completion
Feb 2009
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of PRGF-Endoret in knee osteoarthritis (OA), sponsored by Meir Medical Center. Started Jan 2008; status: completed.

02

Drugs

PRGF-Endoret
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00728611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00728611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call